Published: Feb. 27, 2025 at 1:23 p.m. ET AMC Entertainment Holdings Inc.’s most liquid bond rallied this week, lifted by better-than-expected fourth-quarter revenue at the...
Communications services companies rose as traders bought into defensive, value stocks such as cell-phone carriers, which struggled in 2023. Shares of AT&T and Verizon...
Shares of power producers rose as traders rotated into defensive sectors following inflation data. The utilities sector burst out of the gate in 2024...
By Denny Jacob TransCode Therapeutics said Michael Dudley, co-founder and chief executive, would retire, part of its restructuring intended to further reduce expenses and...
Don’t miss these top money and investing features: Sign up here to get MarketWatch’s best mutual funds and ETF stories emailed to you weekly! INVESTING...
During a challenging year for startups and financial institutions, these entrepreneurs, traders and investors are navigating tough terrain and making an outsized impact. By...
In the last three years, the banking and fintech sectors have undergone significant, foundational changes, profoundly impacting U.S. small businesses. Much of the talk...
The King is dead, long live the king. On Tuesday, November 21, Binance, what was the world’s largest cryptocurrency exchange, and the CEO, Changpeng...
Christopher LiDesjardins Securities Inc., Research Division My pleasure again to welcome Canadian Tire, Darren Myers, about 6 months into the job. Darren MyersExecutive VP...
This article was written by Follow I’m a long-term investor focused on U.S. and European equities, with a dual emphasis on undervalued growth stocks...
This article was written by Follow Pzena Investment Management’s investment philosophy is simple: it seeks to buy good businesses at low prices. Pzena focuses...
Follow Play Earnings CallPlay Earnings Call Praxis Precision Medicines, Inc. (PRAX) Jefferies London Healthcare Conference 2025 November 18, 2025 8:30 AM EST Company Participants...
Panna SharmaPresident, CEO & Director Okay. Thank you, everyone, for joining us today for our LP-184 clinical trial results webinar. We’ll be talking in...
Operator Good day, everyone, and welcome to the Vivos Third Quarter 2025 Conference Call. [Operator Instructions] This conference call is being recorded, and a...